Gene · 81
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| How does plasticity of migration help tumor cells to avoid treatment: Cytoskeletal regulators and potential markers. | Front Pharmacol | 2022 | 36278174 | PubTator, text mining | PubMed |
| Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming. | Theranostics | 2022 | 36276655 | PubTator, text mining | PubMed |
| TRIP13/FLNA Complex Promotes Tumor Progression and Is Associated with Unfavorable Outcomes in Melanoma. | J Oncol | 2022 | 36268276 | PubTator, text mining | PubMed |
| Placental proteome in late‑onset of fetal growth restriction. | Mol Med Rep | 2022 | 36263610 | PubTator, text mining | PubMed |
| TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | Cell Rep | 2022 | 36261009 | PubTator, text mining | PubMed |
| Advances in the application of proteomics in lung cancer. | Front Oncol | 2022 | 36237335 | PubTator, text mining | PubMed |
| Salivary proteomic analysis in asymptomatic and symptomatic SARS-CoV-2 infection: Innate immunity, taste perception and FABP5 proteins make the difference. | Clin Chim Acta | 2022 | 36228679 | PubTator, text mining | PubMed |
| Ex vivo exposures to arsenite and its methylated trivalent metabolites alter gene transcription in mouse sperm cells. | Toxicol Appl Pharmacol | 2022 | 36209798 | PubTator, text mining | PubMed |
| Dysregulated DNA methylation in the pathogenesis of Fabry disease. | Mol Genet Metab Rep | 2022 | 36186841 | PubTator, text mining | PubMed |
| Clinical, Pathological, and Genetic Characteristics in Patients with Focal Segmental Glomerulosclerosis. | Kidney360 | 2022 | 36176665 | PubTator, text mining | PubMed |
| Aortic Cellular Diversity and Quantitative Genome-Wide Association Study Trait Prioritization Through Single-Nuclear RNA Sequencing of the Aneurysmal Human Aorta. | Arterioscler Thromb Vasc Biol | 2022 | 36172868 | PubTator, text mining | PubMed |
| Proteomics Combined with RNA Sequencing to Screen Biomarkers of Sepsis. | Infect Drug Resist | 2022 | 36172619 | PubTator, text mining | PubMed |
| Proteomics profiling identifies extracellular vesicles' cargo associated with tumour cell induced platelet aggregation. | BMC Cancer | 2022 | 36171564 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Whole-exome sequencing of a multicenter cohort identifies genetic changes associated with clinical phenotypes in pediatric nephrotic syndrome. | Genes Dis | 2022 | 36157477 | PubTator, text mining | PubMed |
| Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review. | Discov Oncol | 2022 | 36152065 | PubTator, text mining | PubMed |
| Sarcoidosis and autoimmunity: In the depth of a complex relationship. | Front Med (Lausanne) | 2022 | 36148452 | PubTator, text mining | PubMed |
| Juvenile Membranous Nephropathy Developed after Human Papillomavirus (HPV) Vaccination. | Vaccines (Basel) | 2022 | 36146521 | PubTator, text mining | PubMed |
| Systematic Review of the Role of Alpha-Protein Kinase 1 in Cancer and Cancer-Related Inflammatory Diseases. | Cancers (Basel) | 2022 | 36139553 | PubTator, text mining | PubMed |
| Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability. | Cancers (Basel) | 2022 | 36139525 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81/papers?page=19